• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hoth Therapeutics, Inc. - Common Stock (NQ:HOTH)

1.360 UNCHANGED
Last Price Updated: 4:00 PM EDT, May 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.360
Bid (Size) 1.740 (1,500)
Ask (Size) 1.750 (8,900)
Prev. Close 1.360
Today's Range 1.360 - 1.360
52wk Range 0.4894 - 2.115
Shares Outstanding 23,873,626
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Keep an eye on the top gainers and losers in Wednesday's session. ↗
May 27, 2026
Via Chartmill
Most active stocks in Wednesday's session ↗
May 27, 2026
Via Chartmill

Performance

YTD
+27.1%
+27.1%
1 Month
+91.8%
+91.8%
3 Month
+33.3%
+33.3%
6 Month
+19.3%
+19.3%
1 Year
+46.2%
+46.2%

More News

Read More
Wednesday's session: top gainers and losers ↗
May 27, 2026
Via Chartmill
News headline image
Top stock movements in today's session. ↗
April 14, 2026
Via Chartmill
Topics Artificial Intelligence
News headline image
Most active stocks in Tuesday's session ↗
April 14, 2026
Via Chartmill
Topics Artificial Intelligence
News headline image
Emerging Now: ANY, GPRO, HOTH, SNAL Shift Strategic Focus in 2026
April 14, 2026
Via AB Newswire
Topics Artificial Intelligence Economy
News headline image
Sphere 3D Corp.(NASDAQ: ANY) Transitions to AI Infrastructure Platform as Data Center Demand Surges
April 14, 2026
Via AB Newswire
Topics Artificial Intelligence Economy
News headline image
Tuesday's session: gap up and gap down stocks ↗
April 14, 2026
Via Chartmill
News headline image
Stay updated with the stocks that are on the move in today's pre-market session. ↗
April 14, 2026
Via Chartmill
Top movers analysis one hour before the close of the markets on 2026-04-01: top gainers and losers in today's session. ↗
April 01, 2026
Via Chartmill
News headline image
Hoth Therapeutics's GDNF Treatment Shows Superior Efficacy Over Wegovy, Ozempic In Preclinical Trial ↗
February 10, 2026
Via Stocktwits
BioMedNewsBreaks — Lantern Pharma Inc. (NASDAQ: LTRN) Advancing Drug Discovery with PredictBBB.ai(TM) Partnership
October 22, 2025
Via Investor Brand Network
Topics Artificial Intelligence
Lantern Pharma Inc.’s (NASDAQ: LTRN) AI-powered PredictBBB.ai Platform Helps Hoth Therapeutics Streamline Candidate Selection in Drug Development
October 01, 2025
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
3 Under-the-Radar Biotechs Under $5 That Could Soar 200% ↗
September 09, 2025
Via MarketBeat
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
September 02, 2025
Via Benzinga
News headline image
Curious about the stocks that are showing activity after the closing bell on Tuesday? ↗
September 02, 2025
Via Chartmill
News headline image
Hoth Therapeutics, Inc. (NASDAQ: HOTH) Makes Headlines With Rapid Tumor Kill Data
September 02, 2025
Via News Direct
Hoth Therapeutics, Inc. (NASDAQ: HOTH) Makes Headlines With Rapid Tumor Kill Data
September 02, 2025
Via AB Newswire
News headline image
EXCLUSIVE: Hoth Therapeutics' Antisense Therapy Demonstrates Efficacy Against KIT-Driven Cancers ↗
September 02, 2025
Via Benzinga
News headline image
Top 5 Biotech Stocks With Strong Momentum ↗
August 28, 2025
Via Benzinga
News headline image
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
June 25, 2025
Via Get News
Topics Intellectual Property
News headline image
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
June 25, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
June 25, 2025
Via Press Release Distribution Service
Topics Intellectual Property
News headline image
The trading volume of these stocks is deviating from the norm in today's session. ↗
June 06, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
June 05, 2025
Via Benzinga

Frequently Asked Questions

Is Hoth Therapeutics, Inc. - Common Stock publicly traded?
Yes, Hoth Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Hoth Therapeutics, Inc. - Common Stock trade on?
Hoth Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Hoth Therapeutics, Inc. - Common Stock?
The ticker symbol for Hoth Therapeutics, Inc. - Common Stock is HOTH on the Nasdaq Stock Market
What is the current price of Hoth Therapeutics, Inc. - Common Stock?
The current price of Hoth Therapeutics, Inc. - Common Stock is 1.360
When was Hoth Therapeutics, Inc. - Common Stock last traded?
The last trade of Hoth Therapeutics, Inc. - Common Stock was at 05/27/26 04:00 PM ET
What is the market capitalization of Hoth Therapeutics, Inc. - Common Stock?
The market capitalization of Hoth Therapeutics, Inc. - Common Stock is 32.47M
How many shares of Hoth Therapeutics, Inc. - Common Stock are outstanding?
Hoth Therapeutics, Inc. - Common Stock has 32M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap